Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after stopping their prescription, ...

Several women who have reported improvements in symptoms of polycystic ovary syndrome, a common hormonal disorder, after ...

A cutting-edge mouse study reveals that tirzepatide, the dual GLP-1/GIP drug already hailed for impressive weight loss, does more than trim fat: it slashes the growth of obesity-linked breast tumors.

In a striking new study, the anti-obesity drug tirzepatide, known as Mounjaro and Zepbound, not only triggered significant ...

Concurrent use of menopausal hormone therapy may augment the weight loss benefits of tirzepatide for postmenopausal women ...

GLP-1 drugs like Ozempic and Mounjaro helped men with low testosterone raise their levels without hormone replacement in a ...

A new study suggests that eating more protein while taking GLP-1 medications could help prevent muscle loss, a common side ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

Weight loss injections can help people lose more weight than with other methods of weight loss, including lifestyle changes ...

Modern weight loss medications represent a breakthrough, but they are most effective when combined with the right lifestyle strategies. Here's what that looks like.

Combing a weight-loss drug and hormone therapy may be the key to shedding pounds.

GLP-1 weight-loss drugs are changing how people date and connect. In a nationally representative survey of 2,000 single U.S.